Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
Status:
Recruiting
Trial end date:
2023-06-20
Target enrollment:
Participant gender:
Summary
This study is a multicenter, single-arm, open, phase Ⅱ clinical study to evaluate the safety
and efficacy of Toripalimab(JS001) monoclonal injection after chemotherapy in combination
with Endostar for Locally Advanced or Metastatic Mucosal Melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Collaborators:
Fujian Cancer Hospital The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Zhejiang Cancer Hospital